Studies have demonstrated that quinazoline derivatives exhibit significant inhibitory activity against cholinesterase enzymes implicated in the breakdown of acetylcholine, thereby ameliorating cholinergic transmission deficits observed in AD patients. The gene discussed is BCHE; the disease is Alzheimer disease.